Los puntos clave no están disponibles para este artículo en este momento.
We report the use of avacopan as a component of the treatment for pulmonary haemorrhage with hypoxia in AAV. Despite the life-threatening presentations all patients recovered, but attribution of the positive outcomes to avacopan is limited by the concomitant therapies and retrospective observational design.
Chalkia et al. (Wed,) studied this question.